Search results

11 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Potential pancreatic cancer treatment could increase life expectancy
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.
Located in News
Channing Der presents lecture at Pancreatic Cancer Action Network
Der highlighted recent research findings that have stimulated new experimental directions for improve therapies for pancreatic cancer.
Located in News
Der receives grant funding for pancreatic cancer research
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
Located in News / 2012 News
USA Today looks at pancreatic cancer, Goldberg quoted
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, is quoted in the Health section of USA Today's website.
Located in News / 2011 News
Yeh elected to American Society for Clinical Investigation
UNC Lineberger's Jen Jen Yeh, MD, has been elected to the American Society for Clinical Investigation, an honor society for physician-researchers. A formal induction ceremony was held April 24 at the joint ASCI/AAP meeting in Chicago.
Located in News
Genetic Marker in the Vitamin D Receptor Gene Associated With Increased Overall Survival for Pancreatic Cancer Patients
By Jeremy Moore
Located in News / 2012 News
UNC Team Discovers Promising Target for New Pancreatic Cancer Treatments
Cell signaling protein may hold key to blocking long-studied genetic mutation
Located in News / 2011 News
Der pulls in two grants for pancreatic cancer research
The Pancreatic Cancer Action Network and the American Association for Cancer Research announced April 16 that UNC Lineberger's Channing Der, PhD, and two co-principal investigators were chosen to receive a $1 million grant for pancreatic cancer research. Earlier this year, Der was also announced as the recipient of a grant from The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research.
Located in News
Advocates join together to raise awareness about pancreatic cancer
When scientists and advocates join forces, good things can happen. Dr. Channing Der, Sarah Graham Kenan Professor of Pharmacology and UNC Lineberger faculty member, and Lori Matteson, a Raleigh pancreatic cancer survivor and advocate, joined over 600 other pancreatic cancer advocates and family members on a visit to Washington, DC.
Located in News / 2012 News
UNC Lineberger teams to participate in Pancreatic Cancer Purple Stride 5K
UNC Lineberger will be well represented at the 2014 Pancreatic Cancer Purple Stride 5K. The event, organized by the Pancreatic Cancer Action Network, helps raise awareness and research funds for pancreatic cancer.
Located in News